Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study

NCT07210528 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment (MCI)
Alzheimer Dementia (AD)

Interventions

DRUG: Emtricitabine (FTC)
DRUG: Descovy® (TAF/FTC)
DRUG: Placebo to Match Emtricitabine 200mg/Tenofovir Alafenamide 25 mg.
DRUG: Placebo Capsules to Match Emtricitabine Capsules, 200mg.

Sponsor

National University Hospital, Singapore